Cargando…
Examining the freezing process of an intermediate bulk containing an industrially relevant protein
Numerous biopharmaceuticals are produced in recombinant microorganisms in the controlled environment of a bioreactor, a process known as Upstream Process. To minimize product loss due to physico-chemical and enzymatic degradation, the Upstream Process should be directly followed by product purificat...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370381/ https://www.ncbi.nlm.nih.gov/pubmed/25765305 http://dx.doi.org/10.1016/j.enzmictec.2015.01.003 |
_version_ | 1782362862005518336 |
---|---|
author | Reinsch, Holger Spadiut, Oliver Heidingsfelder, Johannes Herwig, Christoph |
author_facet | Reinsch, Holger Spadiut, Oliver Heidingsfelder, Johannes Herwig, Christoph |
author_sort | Reinsch, Holger |
collection | PubMed |
description | Numerous biopharmaceuticals are produced in recombinant microorganisms in the controlled environment of a bioreactor, a process known as Upstream Process. To minimize product loss due to physico-chemical and enzymatic degradation, the Upstream Process should be directly followed by product purification, known as Downstream Process. However, the Downstream Process can be technologically complex and time-consuming which is why Upstream and Downstream Process usually have to be decoupled temporally and spatially. Consequently, the product obtained after the Upstream Process, known as intermediate bulk, has to be stored. In those circumstances, a freezing procedure is often performed to prevent product loss. However, the freezing process itself is inseparably linked to physico-chemical changes of the intermediate bulk which may in turn damage the product. The present study analysed the behaviour of a Tris-buffered intermediate bulk containing a biopharmaceutically relevant protein during a bottle freezing process. Major damaging mechanisms, like the spatiotemporal redistribution of ion concentrations and pH, and their influence on product stability were investigated. Summarizing, we show the complex events which happen in an intermediate bulk during freezing and explain the different causes for product loss. |
format | Online Article Text |
id | pubmed-4370381 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-43703812015-04-01 Examining the freezing process of an intermediate bulk containing an industrially relevant protein Reinsch, Holger Spadiut, Oliver Heidingsfelder, Johannes Herwig, Christoph Enzyme Microb Technol Article Numerous biopharmaceuticals are produced in recombinant microorganisms in the controlled environment of a bioreactor, a process known as Upstream Process. To minimize product loss due to physico-chemical and enzymatic degradation, the Upstream Process should be directly followed by product purification, known as Downstream Process. However, the Downstream Process can be technologically complex and time-consuming which is why Upstream and Downstream Process usually have to be decoupled temporally and spatially. Consequently, the product obtained after the Upstream Process, known as intermediate bulk, has to be stored. In those circumstances, a freezing procedure is often performed to prevent product loss. However, the freezing process itself is inseparably linked to physico-chemical changes of the intermediate bulk which may in turn damage the product. The present study analysed the behaviour of a Tris-buffered intermediate bulk containing a biopharmaceutically relevant protein during a bottle freezing process. Major damaging mechanisms, like the spatiotemporal redistribution of ion concentrations and pH, and their influence on product stability were investigated. Summarizing, we show the complex events which happen in an intermediate bulk during freezing and explain the different causes for product loss. Elsevier 2015-04 /pmc/articles/PMC4370381/ /pubmed/25765305 http://dx.doi.org/10.1016/j.enzmictec.2015.01.003 Text en © 2015 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Reinsch, Holger Spadiut, Oliver Heidingsfelder, Johannes Herwig, Christoph Examining the freezing process of an intermediate bulk containing an industrially relevant protein |
title | Examining the freezing process of an intermediate bulk containing an industrially relevant protein |
title_full | Examining the freezing process of an intermediate bulk containing an industrially relevant protein |
title_fullStr | Examining the freezing process of an intermediate bulk containing an industrially relevant protein |
title_full_unstemmed | Examining the freezing process of an intermediate bulk containing an industrially relevant protein |
title_short | Examining the freezing process of an intermediate bulk containing an industrially relevant protein |
title_sort | examining the freezing process of an intermediate bulk containing an industrially relevant protein |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370381/ https://www.ncbi.nlm.nih.gov/pubmed/25765305 http://dx.doi.org/10.1016/j.enzmictec.2015.01.003 |
work_keys_str_mv | AT reinschholger examiningthefreezingprocessofanintermediatebulkcontaininganindustriallyrelevantprotein AT spadiutoliver examiningthefreezingprocessofanintermediatebulkcontaininganindustriallyrelevantprotein AT heidingsfelderjohannes examiningthefreezingprocessofanintermediatebulkcontaininganindustriallyrelevantprotein AT herwigchristoph examiningthefreezingprocessofanintermediatebulkcontaininganindustriallyrelevantprotein |